There is growing evidence that activation of the immune system may be an effective
treatment for patients with either small cell lung cancer or non–small cell lung cancer …

FOXP3 is a member of the forkhead/winged‐helix family of transcriptional regulators.
Defects in the FOXP3 gene cause an X‐linked autoimmune/immunodeficiency syndrome in …

Background The role of cancer cell FOXP3 in tumorigenesis is conflicting. We aimed to study
FOXP3 expression and regulation, function and clinical implication in human non-small cell …

Immune cells comprise a substantial proportion of the tumor mass in human nonsmall cell
lung cancers (NSCLC), but the precise composition and significance of this infiltration are …

Introduction Although obesity is associated with adverse cancer outcomes in general, most
retrospective clinical studies suggest a beneficial effect of obesity in NSCLC. Methods …

Prognostic significance of immune cells in non-small cell lung cancer: meta-analysis - PMC
Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI …

FOXP3 is a transcription factor, which belongs to the family of FOX protein. FOXP3 was
initially discovered in regulatory T cells and supposed to play a significant role in the …

The metastasis of cancer is a complex and life-threatening process that is only partially
understood. Immune suppressive cells are recognized as important contributors to tumour …

Background: Forkhead Box P3 (FoxP3) is thought to be a key transcription factor in
regulatory T cells (Tregs), and recent data indicate that it is expressed in several tumour …

NSCLC (non-small cell lung cancer) is the most common type of lung cancer and usually
has poor prognosis. FOXP3 in regulatory T cells (Tregs) and toll-like receptor 4 (TLR4) on …